{
  "id": 11103120,
  "title": "Motilal Oswal Alternates sells over 2% stake in Molbio Diagnostics for ₹306 cr",
  "url": "https://urgent.news/2026/10/01/motilal-oswal-alternates-sells-over-2-stake-in-molbio-diagnostics-for",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-01T04:06:17.000Z",
  "source": {
    "name": "Hindu BusinessLine",
    "slug": "hindu-businessline",
    "url": "https://www.thehindubusinessline.com/markets/motilal-oswal-alternates-sells-over-2-stake-in-molbio-diagnostics-for-306-cr/article71531191.ece"
  },
  "original_language": "en",
  "account": "Motilal Oswal Alternates recently divested nearly 2% of its stake in Molbio Diagnostics through open market transactions, selling 23.28 lakh shares of the Goa-based company. The transaction, conducted on Wednesday, generated ₹306.26 crore for the entity, which held an 11.52% stake in Molbio as of August 2026. Business Excellence Trust III, a fund managed by Motilal Oswal Alternates, executed the sale at an average price of ₹1,315.01 per share. Meanwhile, HDFC Mutual Fund entered the picture by purchasing 23 lakh shares, constituting a 2% stake, for ₹302.45 crore at the same average price. The BSE data did not disclose the identities of the other purchasers. Molbio Diagnostics shares surged 4.07% to close at ₹1,309.45 on the BSE. Earlier this week, Business Excellence Trust III had sold a 2.6% stake in Molbio for ₹394 crore in another bulk deal. Additionally, Gian Parkash Aggarwal offloaded 15.50 lakh shares, or a 2.71% stake, in pharmaceutical company Innova Captab for ₹167 crore through open market transactions. SBI Mutual Fund acquired a 1.45% stake in Innova Captab by buying 8.33 lakh shares for ₹90 crore. However, Innova Captab shares fell 9% to close at ₹1,158.15 apiece on the BSE.",
  "summary": "Business Excellence Trust III, a fund of Motilal Oswal Alternates, offloaded 23.28 lakh shares of Goa-based Molbio Diagnostics at an average price of ₹1,315.01 apiece",
  "key_points": [
    "Motilal Oswal Alternates sold 2% stake in Molbio Diagnostics for ₹306 cr.",
    "Business Excellence Trust III sold 2.6% stake in Molbio for ₹394 cr.",
    "Molbio shares rose 4.07% to close at ₹1,309.45 on BSE."
  ],
  "editors_take": "Motilal Oswal Alternates' sale of a 2% stake in Molbio Diagnostics indicates a partial exit from the company, with HDFC Mutual Fund emerging as a new investor.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}